{"text": ["Big", "Pharma's", "Showdown", "With", "Congress", "Over", "Drug", "Pricing:", "What", "It", "Really", "Means", "for", "You"], "created_at": "2019-02-27 22:09:32"}
{"text": ["Big", "Pharma's", "Showdown", "With", "Congress", "Over", "Drug", "Pricing:", "What", "It", "Really", "Means", "for", "You"], "created_at": "2019-02-27 22:09:32"}
{"text": ["Big", "Pharma&apos;s", "Showdown", "With", "Congress", "Over", "Drug", "Pricing:", "What", "It", "Really", "Means", "for", "You"], "created_at": "2019-02-27 20:49:00"}
{"text": ["The", "patent", "system", "\u2018keeps", "American", "drug", "prices", "so", "high\u2019"], "created_at": "2019-02-27 16:20:02"}
{"text": ["Senate", "panel", "grills", "pharma", "CEO", "over", "executive", "bonuses.", "Calls", "tie", "to", "sales", "of", "AbbVie", "blockbuster", "drug", "Humira", "&apos;problematic&apos;"], "created_at": "2019-02-27 11:00:09"}
{"text": ["Senate", "panel", "grills", "pharma", "CEO", "over", "executive", "bonuses.", "Calls", "tie", "to", "sales", "of", "AbbVie", "blockbuster", "drug", "Humira", "'problematic'"], "created_at": "2019-02-27 11:00:09"}
{"text": ["Voyager", "Therapeutics,", "Inc.", "(VYGR)", "Q4", "2018", "Earnings", "Conference", "Call", "Transcript"], "created_at": "2019-02-27 02:22:51"}
{"text": ["Senators", "Press", "Drug-Company", "Executives", "Over", "Prices"], "created_at": "2019-02-27 01:35:32"}
